Best Judith Basin County Grants for Nonprofits in Montana

The College Well-Being Funding Opportunity aims to enhance the health of college students through innovative programs and research. Offered by the American College Health Foundation, it provides up to two awards of $3,500 to eligible institutions for improving campus infrastructure that promotes student well-being. This initiative encourages creativity and collaboration among campus health professionals to develop effective, measurable outcomes in student wellness. By fostering a culture of well-being, the foundation seeks to address the evolving needs of contemporary students.

The Beth N. Rom-Rymer Travel Scholarship provides $1,000 for Native psychology graduate students to attend the American Psychological Association's annual convention. This opportunity is specifically for members of the Society of Indian Psychologists (SIP). The scholarship aims to support diverse applicants and encourages first-time attendees who demonstrate financial need. APF, the funding organization, is dedicated to enhancing the field of psychology by supporting early career professionals and their contributions to societal improvement.

The Drug Discovery Predoctoral Fellowship by the PhRMA Foundation supports PhD candidates engaged in thesis research in drug discovery. This fellowship offers $30,000 annually for 12 to 24 months, encouraging innovative research that integrates multiple scientific disciplines. Applicants must be full-time, in-residence students at accredited U.S. universities and have completed significant coursework. The funding is conditional upon continued enrollment and is intended for stipend support, with some funds allowable for research-related incidentals.

The Drug Delivery Predoctoral Fellowship by the PhRMA Foundation supports promising PhD candidates in drug delivery research at accredited U.S. universities. It provides $30,000 per year for 12 to 24 months, aimed at enhancing the understanding of drug formulation and delivery technologies. The fellowship emphasizes innovative research that leads to improved patient outcomes and fosters collaboration among diverse research teams, ensuring that all individuals have access to groundbreaking medicines.

The PhRMA Foundation offers a Drug Delivery Postdoctoral Fellowship aimed at fostering biopharmaceutical innovation and enhancing research capabilities in drug delivery. This fellowship supports both U.S. and non-U.S. citizens who are involved in collaborative research training at accredited U.S. universities. Awardees receive a stipend of $60,000 per year for 12 to 24 months, with funding contingent on ongoing employment in the postdoctoral program. Ideal candidates are encouraged to expand their skills in new research environments.

The Drug Discovery Postdoctoral Fellowship by the PhRMA Foundation supports researchers in a multidisciplinary training program at accredited U.S. universities. Aimed at enhancing credentials in drug discovery, it funds innovative research with potential human applications. Proposals should focus on biological validation of drug targets across various scientific disciplines. The fellowship provides $60,000 in annual stipend support for up to 24 months, contingent on the awardee's continued employment at the university.

The Drug Discovery Faculty Starter Grant, offered by the PhRMA Foundation, supports early-career researchers in drug discovery at U.S. universities. With a funding amount of $100,000 for one year, this grant is targeted at faculty members within five years of their independent status. The program aims to foster innovative research that integrates various scientific disciplines, ultimately leading to novel treatments for patients. Eligibility extends to full-time faculty members eligible for promotion.

The Drug Delivery Faculty Starter Grant from the PhRMA Foundation supports early-career researchers in drug delivery, providing $100,000 for one year. Eligible applicants include full-time faculty at accredited U.S. universities within their first five years of independent status. The grant emphasizes innovative research that enhances drug transport and dosage forms. Recipients must notify the Foundation of any external funding exceeding $250,000. This initiative aims to foster scientific independence and collaboration in biopharmaceutical innovation.

The SUS Mid Career Award offers $40,000 for one year to SUS members in the US or Canada with prior research funding, supporting their ongoing work in surgical sciences. Eligible applicants must have experience as a principal investigator on independent or smaller grants, or hold a career development award. This award serves as bridge funding for those who have recently applied for independent grants but were not funded, fostering continued research and innovation.

The Stanford Children's Health Center for IBD and Celiac Disease offers Intramural Seed Grants to promote innovative research in pediatric diseases. This program supports high-risk, high-reward projects, encouraging multi-PI collaborations across disciplines. Awards of up to $100,000 per year for two years are available, aimed at generating preliminary data for future funding applications. Eligible applicants include Stanford faculty holding specific university positions. Proposals should focus on advancing understanding of pediatric IBD and celiac disease through various research approaches.

The Melanoma Research Resident and Fellowship Grant offers $10,000 to support early-career residents and fellows in conducting clinical or laboratory research focused on melanoma. This grant encourages innovative approaches to understanding prevention, detection, and treatment of melanoma, including special emphasis on ocular melanoma. Eligible candidates must have a qualified mentor and conduct research at a U.S. institution. This initiative aims to enhance the landscape of melanoma research and foster the next generation of researchers.

The Celiac Disease Foundation offers the Jocelyn Silvester Rising Villus Student Research Award to encourage medical students and residents to pursue celiac disease research. This prestigious award provides a $5,000 stipend for a 10-week mentored research experience across North America, honoring Dr. Jocelyn Silvester's contributions to the field. Recipients must secure a mentor and maintain good standing in their academic programs, ensuring a commitment to advancing celiac disease research.

The National MS Society's Institutional Clinician Training Award supports the training of neurologists and physiatrists in comprehensive MS care. This program enhances the skills of postdoctoral fellows through mentorship and specialized training, ensuring they are equipped to provide personalized, high-quality care. The Society aims to foster a community of leaders in MS clinical practice, encouraging active participation in research and volunteer opportunities to improve outcomes for individuals with MS.

The Multiple Sclerosis Clinical Care Physician Fellowship is a one-year program by the National Multiple Sclerosis Society aimed at training neurologists and physiatrists in specialized clinical care for MS patients. Eligible candidates include PGY3 or PGY4 residents from U.S. programs. The fellowship focuses on supervised patient care, multidisciplinary team activities, and professional development, preparing fellows to provide high-quality care and to engage as future leaders in the MS community.

The Multiple Sclerosis Clinical Care Physician Fellowship: Pediatric Care, offered by the National Multiple Sclerosis Society, aims to enhance the training of physicians in providing specialized care for pediatric patients with MS. This one-year post-residency program emphasizes direct patient care and multidisciplinary collaboration. Participants will learn under the supervision of MS specialists, gaining essential skills to improve clinical practices and contribute to the MS community, ultimately leading to better outcomes for those affected by this condition.

The MRFBC Young Investigator Team Award supports innovative research in immuno-oncology for melanoma, offering up to $150,000 annually for two years. This funding targets U.S.-based researchers aiming to enhance clinical outcomes for melanoma patients or deepen the scientific understanding of immuno-oncology. The MRF collaborates with key institutions to address challenges in melanoma research, fostering partnerships that maximize research potential and impact.

The National Multiple Sclerosis Society offers Career Transition Fellowships aimed at fostering young scientists in MS research. This program supports postdoctoral trainees with a doctoral degree and exceptional potential, providing funding for advanced training and faculty support over five years. Applicants must demonstrate relevance to high-priority research questions outlined in the Society's Pathways to Cures Roadmap, which focuses on stopping MS, restoring function, and ending the disease through prevention.

The Melanoma Established Investigator Award offers up to $125,000 annually for two years, aimed at established melanoma researchers or senior researchers transitioning into melanoma research. Eligible applicants include Associate Professors or higher, with both tenured and non-tenured faculty encouraged to apply. U.S. citizenship is not a requirement for this funding opportunity provided by the Melanoma Research Foundation.

The National Multiple Sclerosis Society offers Postdoctoral Fellowships to support innovative research aimed at advancing the understanding and treatment of multiple sclerosis. These fellowships are designed for promising researchers holding advanced degrees, providing funding for training that enhances their ability to conduct impactful studies. The Society prioritizes applications that align with high-priority research questions outlined in its Pathways to Cures Roadmap, emphasizing the importance of diverse methodologies and engagement with underserved populations.

The Sidney R. Baer, Jr. Foundation focuses on improving the lives of individuals with schizophrenia and bipolar disorder through education grants. By funding programs that enhance educational opportunities, the foundation aims to reduce isolation and promote understanding. Grants are awarded to qualified organizations that prioritize mental health initiatives, ensuring that those affected have access to the resources and support necessary for a better quality of life. The foundation's mission is rooted in the belief that education can be transformative for those facing mental health challenges.

The Sidney R. Baer, Jr. Foundation offers Criminal Justice Grants aimed at improving the lives of individuals with serious mental illnesses, particularly schizophrenia and bipolar disorder. With an emphasis on effective programs and support services, the foundation seeks to address the challenges faced by mentally ill individuals in the criminal justice system. The foundation prioritizes organizations that demonstrate a commitment to making a meaningful impact and improving the quality of life for those affected by these conditions.

The Sidney R. Baer, Jr. Foundation offers Reintegration Grants aimed at supporting individuals with schizophrenia and bipolar disorder. By focusing on abilities rather than symptoms, the foundation promotes recovery through various programs. Their funding helps organizations that maintain a commitment to mental health, ensuring that recipients receive necessary support, such as scholarships and facility management, to enhance their quality of life. The foundation believes in empowering individuals to actively participate in their recovery journey.

The Sidney R. Baer, Jr. Foundation offers Social Support Grants aimed at improving the lives of individuals living with schizophrenia and bipolar disorder. These grants focus on reducing stigma through education and advocacy, fostering a compassionate environment. The foundation prioritizes organizations that provide tangible support and resources, ensuring a meaningful impact on mental health. By addressing the challenges faced by those with mental illness, the foundation strives to create a more inclusive society that recognizes and supports their needs.

The Sidney R. Baer, Jr. Foundation offers Clinical Research Grants to support advancements in the treatment and understanding of schizophrenia and bipolar disorder. Focused on organizations with IRS tax-exempt status, these grants aim to enhance mental health services and research. By funding initiatives in cognitive and behavioral sciences, the foundation seeks to improve the lives of those affected by serious mental illness, ensuring they receive the support and resources necessary for a better quality of life.

The Melanoma Career Development Award (CDA) is offered by the Melanoma Research Foundation to support researchers dedicated to melanoma and its prevention. This award is designed for postdoctoral fellows with under five years of experience, research associates, scientists, staff scientists, assistant professors, and those focusing on melanoma prevention. The initiative promotes innovative research to advance understanding and treatment of melanoma, ultimately aiming to reduce its impact.

The Cooperative Education Fund, managed by the Cooperative Development Foundation, offers grants, scholarships, and sponsorships to support cooperative education initiatives. Annually, it allocates between $100,000 and $140,000, providing 10-15 grants ranging from $1,000 to $10,000. Eligible applicants include cooperatives and related organizations within the U.S. The Fund prioritizes research, educational material development, and sponsorship for educational events, ensuring resources remain accessible and non-proprietary.

The Cooperative Development Fund Grant supports cooperative development, research, and technical assistance for cooperatives focused on seniors, international development, and affordable housing. Grants, typically ranging from $20,000 to $30,000, are awarded once a year, with a two-stage application process: a concept paper followed by a full proposal for selected applicants. Up to two grants are awarded annually, with decisions announced shortly after the Advisory Board meeting in January.